Find and study cells that make diseases incurable
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Durham
State: North Carolina
Zip:
Country: United States
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company’s TrapTx Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to tens of thousands of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2017 | Convertible Note | $225k | 9/2018 | Grant | 1 | $1.5M |
National Institutes of Health National Institutes of Health |
4/2021 | Seed Round | 1 | - |
TSVC TSVC |
1/2017 | Grant | 1 | $225k |
National Institutes of Health National Institutes of Health |
1/2021 | Venture Round | - |
Life Science Angels Life Science Angels |
4/2021 | Seed Round | 1 | - |
TSVC TSVC |
1/2021 | Venture Round | 1 | - |
Life Science Angels Life Science Angels |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|